Home » NOVARTIS SEES EON LABS APPROVAL NOT BEFORE JULY
NOVARTIS SEES EON LABS APPROVAL NOT BEFORE JULY
Swiss drugmaker Novartis AG does not expect U.S. approval for its takeover of U.S. generics maker Eon Labs before July 8 and has extended its tender offer for the shares into next month.
Novartis said in a statement on Tuesday that the offer for all outstanding public shares in Eon Labs was extended to July 1 from June 20. However, it does not expect U.S. regulatory approval for the takeover to come before a court hearing on litigation by shareholders that is scheduled for July 8. "Novartis does not currently expect to receive regulatory approval prior to the court's hearing," Novartis said.
()a href="http://go.reuters.com/newsArticle.jhtml?type=topNews&storyID=8850110" target="_blank">Reuters
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May